These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 27942097)
1. Sociodemographic profiles and use-dynamics of Jadelle (levonorgestrel) implants in Jos, Nigeria. Pam VC; Mutihir JT; Nyango DD; Shambe I; Egbodo CO; Karshima JA Niger Med J; 2016; 57(6):314-319. PubMed ID: 27942097 [TBL] [Abstract][Full Text] [Related]
2. Predictors of Discontinuation of Subdermal Levonorgestrel Implants (Jadelle) at the Lagos University Teaching Hospital, Lagos, Nigeria: An Analytic Cohort Study. Ohazurike E; Olamijulo JA; Ibisomi L; Olorunfemi G; Oluwole AA Afr J Reprod Health; 2020 Jun; 24(2):48-63. PubMed ID: 34077091 [TBL] [Abstract][Full Text] [Related]
3. Jadelle subdermal implants. Preliminary experience in a teaching hospital in the Niger Delta Region of Nigeria. Enyindah CE; Kasso T Niger J Med; 2011; 20(2):270-4. PubMed ID: 21970242 [TBL] [Abstract][Full Text] [Related]
4. Transition from Norplant to Jadelle in a clinic with extensive experience providing contraceptive implants. Brache V; Faundes A; Alvarez F; García AG Contraception; 2006 Apr; 73(4):364-7. PubMed ID: 16531168 [TBL] [Abstract][Full Text] [Related]
5. Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital. Laphikanont W; Taneepanichskul S J Med Assoc Thai; 2006 Jun; 89(6):761-6. PubMed ID: 16850674 [TBL] [Abstract][Full Text] [Related]
6. Indications for removal of etonogestrel implant within two years of use in Jos, Nigeria. Mutihir JT; Nyango DD East Afr Med J; 2010 Nov; 87(11):461-4. PubMed ID: 23457809 [TBL] [Abstract][Full Text] [Related]
7. New Zealand women's experience during their first year of Jadelle® contraceptive implant. Roke C; Roberts H; Whitehead A J Prim Health Care; 2016 Mar; 8(1):13-9. PubMed ID: 27477370 [TBL] [Abstract][Full Text] [Related]
8. Experience with Norplant at a Nigerian teaching hospital. Mutihir JT; Aisien AO; Ujah IA East Afr Med J; 2010 Nov; 87(11):456-60. PubMed ID: 23457808 [TBL] [Abstract][Full Text] [Related]
9. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Modesto W; Bahamondes MV; Bahamondes L Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309 [TBL] [Abstract][Full Text] [Related]
13. Norplant-2 subdermal contraceptive system: experience in Taiwan. Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of safety, efficacy, and acceptability of NORPLANT implants in Sri Lanka. Basnayake S; Thapa S; Balogh SA Stud Fam Plann; 1988; 19(1):39-47. PubMed ID: 3129828 [TBL] [Abstract][Full Text] [Related]
15. Contraception with levonorgestrel subdermal implants (Norplant) in Benin-City, Nigeria: a 12-year review. Aisien AO Afr J Reprod Health; 2007 Apr; 11(1):90-7. PubMed ID: 17982951 [TBL] [Abstract][Full Text] [Related]
16. In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant data. Callahan RL; Taylor D; Jenkins DW; Owen DH; Cheng L; Cancel AM; Dorflinger LJ; Steiner MJ Contraception; 2015 Oct; 92(4):350-5. PubMed ID: 26142619 [TBL] [Abstract][Full Text] [Related]
17. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception. Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746 [TBL] [Abstract][Full Text] [Related]
18. Levonorgestrel release rates measured through analysis of two-rod contraceptive explants. Fuchs R; Taylor D; Jenkins DW; Brache V; Luo D; Dorflinger LJ; Steiner MJ Contracept X; 2020; 2():100039. PubMed ID: 32995746 [TBL] [Abstract][Full Text] [Related]
19. NORPLANT contraceptive implants advancing. Segal SJ Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797 [TBL] [Abstract][Full Text] [Related]
20. Determinants of early implant discontinuation among low-income women. Kalmuss D; Davidson AR; Cushman LF; Heartwell S; Rulin M Fam Plann Perspect; 1996; 28(6):256-60. PubMed ID: 8959415 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]